var singsData = [{"date":new Date(2012,1,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Jefferies upgrades EXPD to Buy from Hold. Target Price is $53; previously $42.","showOnAxis":false},{"date":new Date(2012,1,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,1,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades EXPD from Hold. Target Price is $46.","showOnAxis":false},{"date":new Date(2012,10,29),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.28","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,6),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, EXPD reports 2012 Q3's earning $0.42 per share and revenue $1530MM. This misses analyst's estimated EPS $0.43, misses estimated revenue $1600MM.","showOnAxis":false},{"date":new Date(2012,2,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,3,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,3,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,3,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains EXPD to Neutral. Target Price is $51; previously $56.","showOnAxis":true},{"date":new Date(2012,3,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,2),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2012 Q1's earning $0.36 per share and revenue $1411MM..","showOnAxis":false},{"date":new Date(2012,4,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,30),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.28","showOnAxis":true},{"date":new Date(2012,6,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs initiates coverage on EXPD to Sell. Target Price is $35.","showOnAxis":true},{"date":new Date(2012,7,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,7,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,7,7),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2012 Q2's earning $0.39 per share and revenue $1500MM. This misses analyst's estimated EPS $0.43, misses estimated revenue $1590MM.","showOnAxis":false},{"date":new Date(2012,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains EXPD to Sell. Target Price is $34; previously $35.","showOnAxis":true},{"date":new Date(2012,7,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains EXPD to Buy. Target Price is $41; previously $49.","showOnAxis":true},{"date":new Date(2012,9,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains EXPD to Neutral. Target Price is $40; previously $36.","showOnAxis":true},{"date":new Date(2012,9,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee initiates coverage on EXPD to Buy. Target Price is $53.","showOnAxis":true},{"date":new Date(2012,9,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades EXPD to Buy from Sell. Target Price is $42; previously $34.","showOnAxis":false},{"date":new Date(2012,9,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains EXPD to Buy. Target Price is $44; previously $41.","showOnAxis":true},{"date":new Date(2013,0,18),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Credit Suisse upgrades EXPD to Outperform from Neutral. Target Price is $50; previously $42.","showOnAxis":false},{"date":new Date(2013,0,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains EXPD to Buy. Target Price is $47; previously $44.","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2012 Q4's earning $0.4 per share and revenue $1530MM. This misses analyst's estimated EPS $0.43, beats estimated revenue $1510MM.","showOnAxis":false},{"date":new Date(2013,1,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains EXPD to Buy. Target Price is $44; previously $47.","showOnAxis":true},{"date":new Date(2013,10,27),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.3","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2013 Q3's earning $0.45 per share and revenue $1535MM. This misses analyst's estimated EPS $0.49, misses estimated revenue $1590MM.","showOnAxis":false},{"date":new Date(2013,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades EXPD to Neutral from Buy. Target Price is $45; previously $49.","showOnAxis":true},{"date":new Date(2013,11,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,11,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,11,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,11,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,2,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,2,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie initiates coverage on EXPD to Neutral. Target Price is $38.25.","showOnAxis":true},{"date":new Date(2013,2,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Edward Jones initiates coverage on EXPD to Buy.","showOnAxis":true},{"date":new Date(2013,3,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital downgrades EXPD to Underperform from Sector Perform. Target Price is $33; previously $39.","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,1),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, EXPD reports 2013 Q1's earning $0.39 per share and revenue $1410MM. This misses analyst's estimated EPS $0.4, meets estimated revenue $1410MM.","showOnAxis":false},{"date":new Date(2013,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,4,30),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.3","showOnAxis":true},{"date":new Date(2013,5,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stephens & Co. upgrades EXPD to Overweight from Equal-Weight. Target Price is $45; previously $40.","showOnAxis":false},{"date":new Date(2013,6,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research initiates coverage on EXPD to Buy. Target Price is $50.","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,6),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2013 Q2's earning $0.45 per share and revenue $1500MM. This beats analyst's estimated EPS $0.43, misses estimated revenue $1540MM.","showOnAxis":false},{"date":new Date(2013,7,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus downgrades EXPD to Hold from Buy; previously $40.","showOnAxis":true},{"date":new Date(2013,8,16),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,9,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,9,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,9,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,9,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2013,9,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"RBC Capital upgrades EXPD to Outperform from Underperform. Target Price is $50; previously $40.","showOnAxis":false},{"date":new Date(2014,1,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2013 Q4's earning $0.41 per share and revenue $1630MM. This misses analyst's estimated EPS $0.47, beats estimated revenue $1580MM.","showOnAxis":false},{"date":new Date(2014,10,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.32","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades EXPD to Underperform from Neutral. Target Price is $41; previously $43.","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura initiates coverage on EXPD to Neutral. Target Price is $47.","showOnAxis":true},{"date":new Date(2014,11,17),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,11,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,2,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital downgrades EXPD to Market Perform from Outperform. Target Price is $45; previously $48.","showOnAxis":true},{"date":new Date(2014,2,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Avondale Partners downgrades EXPD to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2014,4,13),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,13),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Susquehanna upgrades EXPD to Positive from Neutral. Target Price is $55; previously $44.","showOnAxis":false},{"date":new Date(2014,4,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,4,29),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.32","showOnAxis":true},{"date":new Date(2014,4,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains EXPD to Outperform. Target Price is $45; previously $44.","showOnAxis":true},{"date":new Date(2014,4,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,5,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,7,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades EXPD to Neutral from Outperform. Target Price is $43; previously $45.","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,7,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays initiates coverage on EXPD to Underweight. Target Price is $38.","showOnAxis":true},{"date":new Date(2014,9,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2014,9,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EXPD to Underweight. Target Price is $39; previously $38.","showOnAxis":true},{"date":new Date(2015,0,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EXPD to Underweight. Target Price is $43; previously $39.","showOnAxis":true},{"date":new Date(2015,1,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades EXPD to Equal-Weight from Underperform. Target Price is $46; previously $41.","showOnAxis":false},{"date":new Date(2015,1,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,27),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.36","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,10,3),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2015 Q3's earning $0.62 per share and revenue $1651MM. This beats analyst's estimated EPS $0.6, misses estimated revenue $1790MM.","showOnAxis":false},{"date":new Date(2015,10,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research downgrades EXPD to Neutral from Buy.","showOnAxis":true},{"date":new Date(2015,10,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie maintains EXPD to Neutral. Target Price is $52; previously $51.","showOnAxis":true},{"date":new Date(2015,10,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,11,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research initiates coverage on EXPD to Neutral. Target Price is $44.","showOnAxis":true},{"date":new Date(2015,2,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,2,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,3,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,18),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,4,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,4,28),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.36","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EXPD to Underweight. Target Price is $45; previously $43.","showOnAxis":true},{"date":new Date(2015,5,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,5,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,5,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EXPD to Underweight. Target Price is $44; previously $45.","showOnAxis":true},{"date":new Date(2015,7,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Susquehanna downgrades EXPD to Neutral from Positive.","showOnAxis":true},{"date":new Date(2015,7,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades EXPD to Equal-Weight from Underweight. Target Price is $52; previously $44.","showOnAxis":false},{"date":new Date(2015,7,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2015,7,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades EXPD to Buy from Hold. Target Price is $56.","showOnAxis":false},{"date":new Date(2015,7,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,7,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains EXPD to Equal-Weight. Target Price is $51; previously $52.","showOnAxis":true},{"date":new Date(2016,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital downgrades EXPD to Sector Perform from Outperform. Target Price is $46; previously $56.","showOnAxis":true},{"date":new Date(2016,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades EXPD to Sell from Neutral.","showOnAxis":true},{"date":new Date(2016,1,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains EXPD to Underperform. Target Price is $42; previously $43.","showOnAxis":true},{"date":new Date(2016,10,29),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.4","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2016 Q3's earning $0.59 per share and revenue $1562MM. This misses analyst's estimated EPS $0.65, misses estimated revenue $1570MM.","showOnAxis":false},{"date":new Date(2016,10,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,2,15),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cowen & Co. initiates coverage on EXPD to Market Perform. Target Price is $53.","showOnAxis":true},{"date":new Date(2016,3,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades EXPD to Overweight from Equal-Weight. Target Price is $58; previously $51.","showOnAxis":false},{"date":new Date(2016,3,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Barclays upgrades EXPD to Overweight from Equal-Weight. Target Price is $58; previously $51.","showOnAxis":false},{"date":new Date(2016,3,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BB&T Capital downgrades EXPD to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,3,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stephens & Co. downgrades EXPD to Equal-Weight from Overweight.","showOnAxis":true},{"date":new Date(2016,4,20),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,4,27),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.4","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,4,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,4,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,4,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,4,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,16),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Fair disclosure\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,7,2),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, EXPD reports 2016 Q2's earning $0.63 per share and revenue $1475MM. This beats analyst's estimated EPS $0.59, misses estimated revenue $1520MM.","showOnAxis":false},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains EXPD to Sell. Target Price is $43; previously $42.","showOnAxis":true},{"date":new Date(2016,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wolfe Research downgrades EXPD to Underperform from Peer Perform.","showOnAxis":true},{"date":new Date(2016,7,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus downgrades EXPD to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,7,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2016,7,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true}];